Przemek Obloj

Investor and operator in health, life sciences & technology

📍 United Kingdom🔄 Updated September 2026💼 9 investments📅 19 years investing🗓 Last invested Jan 2021
VC🌍 United Kingdom
9
Total investments
1
Early stage
1
Mid stage
2
Late stage
19y
Years active

Portfolio

6 investments · sorted by recency
All investments
Early stage
Mid stage
Late stage
Investor
2021
bit.bio is an award-winning human synthetic biology company - our mission: coding cells for novel cures. We have developed an end-to-end platform for the creation of any human cell type. With our cutting-edge and patent-protected opti-ox precision cell programming technology, we can deterministically program human iPSCs into a chosen cell identity with unprecedented biological consistency at an industrial scale, and approximately 10 times faster than conventional methods. Our platform has the potential to unlock a new generation of medicines. Our io Cells research products provide scientists access to highly characterised, consistent, scalable human cells that enable research and drug discovery teams to accelerate their experimental timelines and reduce experimental variability, providing an important alternative to traditional workflows. We are also leveraging our platform to build a pipeline of txCells for cell therapies. To achieve our goals, we have assembled a team of pioneers in stem cell biology, cell programming, mathematical modelling and cell therapy. We are empirical, highly ambitious and driven by a shared vision. Collaboration is at the heart of bit.bio. Join us on our journey. For more information on bit.bio’s trademarks, visit www.bit.bio/trademarks
Board Member
2019
Collective Health is the leading health benefits platform that brings together medical, dental, vision, pharmacy, and program partners into an integrated solution that better enables employees and their families to understand, navigate, and pay for healthcare. By reducing the administrative lift of delivering health benefits, providing an intuitive member experience, and helping control costs and improve outcomes, the company guides employees toward healthier lives and companies toward healthier bottom lines. *We value respectful and constructive conversation. Comments that are offensive, inappropriate, or unrelated to the discussion may be removed.*
Investor
2019
**Snowflake is proud to be the Official Data Collaboration Provider for LA28 and Team USA.** Snowflake delivers the AI Data Cloud — a global network where thousands of organizations mobilize data with near-unlimited scale, concurrency, and performance. Inside the AI Data Cloud, organizations unite their siloed data, easily discover and securely share governed data, and execute diverse analytic workloads. Wherever data or users live, Snowflake delivers a single and seamless experience across multiple public clouds. Snowflake’s platform is the engine that powers and provides access to the AI Data Cloud, creating a solution for data warehousing, data lakes, data engineering, data science, data application development, and data sharing. Join Snowflake customers, partners, and data providers already taking their businesses to new frontiers in the AI Data Cloud.
Investor
2019
Galderma is the leading company solely dedicated to skin and advancing the future of dermatology. We deliver an innovative, science-based portfolio of sophisticated brands and services across Injectable Aesthetics, Dermatological Skincare and Therapeutic Dermatology. Through trusted partnerships with healthcare professionals, we ensure to meet individual consumer and patient needs with superior outcomes.
Investor
2017
For more than forty years, AlixPartners has helped businesses around the world respond quickly and decisively to their most critical challenges – circumstances as diverse as urgent performance improvement, accelerated transformation, complex restructuring and risk mitigation. These are the moments when everything is on the line – a sudden shift in the market, an unexpected performance decline, a time-sensitive deal, a fork-in-the-road decision. But it’s not what we do that makes a difference, it’s how we do it. Tackling situations when time is of the essence is part of our DNA – so we adopt an action-oriented approach at all times. We work in small, highly qualified teams with specific industry and functional expertise, and we operate at pace, moving quickly from analysis to implementation. We stand shoulder to shoulder with our clients until the job is done, and only measure our success in terms of the results we deliver. Our approach enables us to help our clients confront and overcome truly future-defining challenges. We partner with you to make the right decisions and take the right actions. And we are right by your side. When it really matters. Recent Awards & Recognition: - Best Firm to Work For – Consulting Magazine, 2023 - Best Places to Work For LGBTQ+ Equality – Human Rights Campaign, 2022 - Best Management Consulting Firms – Forbes, 2021 - Ranked in the Top 10 in UHLALA Group’s Pride Index
Board Member
2016
SKY Leasing is a full-service aircraft leasing company. Launched in October, 2015, SKY provides aircraft leasing and innovative lease management services to airline and airline investors worldwide. Headquartered in San Francisco, SKY strengthens its international development through a network of local representatives and offices in San Francisco, and Miami. SKYs value lies in its experience, deep networks, industry insights, and superior client service. The companys team of industry professionals, maintains strong relationships with over 100 airline customers in every major and developing commercial aviation market around the globe. They have a reputation throughout the industry for providing an unparalleled level of knowledge and consultative expertise to their customers, helping them to meet their business goals.
Experience · 13 entries
All (13)
Investments (9)
Board (4)
2021
Investor
2021
bit.bio is an award-winning human synthetic biology company - our mission: coding cells for novel cures. We have developed an end-to-end platform for the creation of any human cell type. With our cutting-edge and patent-protected opti-ox precision cell programming technology, we can deterministically program human iPSCs into a chosen cell identity with unprecedented biological consistency at an industrial scale, and approximately 10 times faster than conventional methods. Our platform has the potential to unlock a new generation of medicines. Our io Cells research products provide scientists access to highly characterised, consistent, scalable human cells that enable research and drug discovery teams to accelerate their experimental timelines and reduce experimental variability, providing an important alternative to traditional workflows. We are also leveraging our platform to build a pipeline of txCells for cell therapies. To achieve our goals, we have assembled a team of pioneers in stem cell biology, cell programming, mathematical modelling and cell therapy. We are empirical, highly ambitious and driven by a shared vision. Collaboration is at the heart of bit.bio. Join us on our journey. For more information on bit.bio’s trademarks, visit www.bit.bio/trademarks
2020
Managing Partner & CIO
2020
Blue Horizon is accelerating the global transition to a Sustainable Food System. We invest holistically in the Sustainable Food System, with an end-to-end approach that extends beyond alternative proteins, starting with better crop practices right through to sustainable packaging and smarter distribution. We generate impactful investments with a philosophy we call Double Positive — positive, above-market returns for investors and positive, measurable impact for the planet, humans and animals.
2019
Board Member
2019
Collective Health is the leading health benefits platform that brings together medical, dental, vision, pharmacy, and program partners into an integrated solution that better enables employees and their families to understand, navigate, and pay for healthcare. By reducing the administrative lift of delivering health benefits, providing an intuitive member experience, and helping control costs and improve outcomes, the company guides employees toward healthier lives and companies toward healthier bottom lines. *We value respectful and constructive conversation. Comments that are offensive, inappropriate, or unrelated to the discussion may be removed.*
Investor
2019
**Snowflake is proud to be the Official Data Collaboration Provider for LA28 and Team USA.** Snowflake delivers the AI Data Cloud — a global network where thousands of organizations mobilize data with near-unlimited scale, concurrency, and performance. Inside the AI Data Cloud, organizations unite their siloed data, easily discover and securely share governed data, and execute diverse analytic workloads. Wherever data or users live, Snowflake delivers a single and seamless experience across multiple public clouds. Snowflake’s platform is the engine that powers and provides access to the AI Data Cloud, creating a solution for data warehousing, data lakes, data engineering, data science, data application development, and data sharing. Join Snowflake customers, partners, and data providers already taking their businesses to new frontiers in the AI Data Cloud.
Investor
2019
Galderma is the leading company solely dedicated to skin and advancing the future of dermatology. We deliver an innovative, science-based portfolio of sophisticated brands and services across Injectable Aesthetics, Dermatological Skincare and Therapeutic Dermatology. Through trusted partnerships with healthcare professionals, we ensure to meet individual consumer and patient needs with superior outcomes.
Show all 13 entries ↓
Investment activity
2007–2021 · 9 investments
200712016120172201812019320211
Recent (last 2 years)Earlier